Veneto Tumour Registry - Results from #80

Epidemiological surveillance of malignant mesothelioma cases in Italy: incidence and asbestos exposure figures by the Italian mesothelioma registry (ReNaM)
Epidemiology of glial and non-glial brain tumours in Europe
Epidemiology of rare cancers and inequalities in oncologic outcomes
Epidemiology, pathological characteristics and survival of retroperitoneal soft‑tissue sarcomas compared with non‑retroperitoneal soft tissue sarcomas.
Esito clinico delle lesioni CIN2 trattate
Esophageal cancer in the Veneto Region: when pathology-based Cancer Registry does no fit to the expectancies
Esophageal cancer in the Veneto Region: when pathology-based Cancer Registry does no fit to the expectancies
Estimating cancer costs by using cancer registry and administrative data at individual level
Estimating cancer costs by using cancer registry and administrative data at individual level
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study
Fruit and vegetables consumption is directly associated to survival after prostate cancer
Geographical and temporal differences in gastric and oesophageal cancer registration by subsite and morphology in Europe
Geographical differences in cancer prognosis: Italy, 2010-2018
Geographical variability in survival of European children with central nervous system tumours
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Health Outcomes and Direct Healthcare Costs in Patients with Melanoma: Associations with Level of Education
HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2
HPV vaccination in women treated for Cervical Intraepithelial Neoplasia grade 2 or 3: evidence-based recommendation from the Multisociety Italian Guidelines for cervical cancer prevention

Page 5 of 13

This website uses cookies to ensure you get the best experience. Learn more about it.